Lippincott Williams & Wilkins

SHERPA: Unknown

People

  1. Abu-Rustum
    Abu-Rustum
  2. Nelson
    Nelson
  3. Chi
    Chi
  4. Park
    Park
  5. Long Roche
    Long Roche
  6. Raj
    Raj
  7. Aghajanian
    Aghajanian
  8. Jarnagin
    Jarnagin
  9. Leitao
    Leitao
  10. Mehrara
    Mehrara

Groups

  1. Surgery (81)
  2. Department of Medicine (67)
  3. Graduate Medical Education (51)
  4. Solid Tumor Oncology Division (49)
  5. Department of Pathology and Laboratory Medicine (47)
  6. Gynecology Disease Management Team (47)
  7. Survivorship Research (40)
  8. GME, Surgery (34)
  9. Sloan Kettering Institute Postdocs (32)
  10. Epidemiology and Biostatistics (27)
Search Within
  1. "2022"
Formats
  1. Journal Article (99)
  2. Meeting Abstract (59)
  3. Review (35)
  4. Editorial (14)
  5. Guidelines (6)
  6. Correspondence (4)
  7. Research Letter (3)
  8. Conference Paper (2)
  9. Miscellaneous (1)
Groups
  1. Surgery (81)
  2. Department of Medicine (67)
  3. Graduate Medical Education (51)
  4. Solid Tumor Oncology Division (49)
  5. Department of Pathology and Laboratory Medicine (47)
  6. Gynecology Disease Management Team (47)

More Groups

People
  1. Nadeem Abu-Rustum (15)
  2. Jonas Nelson (12)
  3. Evan Matros (10)
  4. Dennis Chi (9)
  5. Kay Park (9)
  6. Diane Reidy (8)

More People

Years
  1. 2022 (223)
Publications
  1. International Journal of Gynecological Cancer (37)
  2. Annals of Surgery (20)
  3. American Journal of Surgical Pathology (18)
  4. Plastic and Reconstructive Surgery (16)
  5. Pancreas (11)
  6. Critical Care Medicine (10)

More Publications

Results (223)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical benefit of mirvetuximab soravtansine in ovarian cancer patients with high folate receptor alpha expression: Results from the SORAYA Study
    Meeting Abstract

    Coleman, R. L.; Matulonis, U.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Marin, M. R.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Phase 2 results of relacorilant + nabpaclitaxel in patients with recurrent, platinum-resistant ovarian cancer with and without prior bevacizumab
    Meeting Abstract

    Colombo, N.; Van Gorp, T.; Matulonis, U.; Oaknin, A.; Grisham, R.; Fleming, G.; Olawaiye, A.; Tudor, I. C.; Pashova, H.; Lorusso, D.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Role of adjuvant therapy in intermediate-risk cervical cancer patients - SCCAN study sub-analysis
    Meeting Abstract

    Cibula, D.; Akilli, H.; van Lonkhuijzen, Lrcw; Fagotti, A.; Dostálek, L.; Ortiz, D. I.; Meydanli, M. M.; Abu-Rustum, N. R.; Odetto, D.; Landoni, F.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer - Going to the next level: A Memorial Sloan Kettering team ovary study
    Meeting Abstract

    Kahn, R.; McMinn, E.; Boerner, T.; Roche, K. L.; Zivanovic, O.; Gardner, G.; Sonoda, Y.; O'Cearbhaill, R.; Grisham, R.; Huang, J.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Outcomes of gynaecological cancer surgery during the COVID-19 pandemic: Results from the international, multicenter, prospective CovidSurg-Gynaecological Cancer study
    Meeting Abstract

    Fotopoulou, C.; Khan, T.; Bracinik, J.; Glasbey, J.; Abu-Rustum, N.; Chiva, L.; Fagotti, A.; Fujiwara, K.; Ghebre, R.; Gutelkin, M.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Updated safety of lenvatinib + pembrolizumab vs treatment of physician's choice in patients with advanced endometrial cancer: Study 309/KEYNOTE-775
    Meeting Abstract

    Makker, V.; Colombo, N.; Casado Herráez, A.; Monk, B.; Mackay, H.; Santin, A.; Miller, D.; Moore, R.; Ray-Coquard, I.; Shapira-Frommer, R.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants in DNA repair genes and endometrial cancer risk
    Meeting Abstract

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K.; Catchings, A.; Maio, A.; Kemel, Y.; Manning-Geist, B.; Sia, T.; Roche, K. L.; Leitao, M.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study
    Meeting Abstract

    Gien, L.; Enserro, D.; Block, M.; Waggoner, S.; Duska, L.; Hendrickson, A. W.; Thaker, P.; Backes, F.; Bottsford-Miller, J.; Muller, C.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Molecular stratification of ovarian clear cell carcinoma predicts clinical outcomes
    Meeting Abstract

    Gordhandas, S.; Manning-Geist, B.; Hodgson, A.; Zhou, Q.; Iasonos, A.; Chi, D.; Momeni-Boroujeni, A.; Abu-Rustum, N.; Leitao, M.; Roche, K. L.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical impact in patients with cervical cancer: Subgroup analysis of the SCCAN project
    Meeting Abstract

    Dostálek, L.; Benešová, K.; Klát, J.; Kim, S. H.; Falconer, H.; Kostun, J.; Ricardo, D. R.; Zapardiel, I.; Ortiz, D. I.; van Lonkhuijzen, L. R. C. W.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save